期刊
CURRENT OPINION IN BIOTECHNOLOGY
卷 22, 期 6, 页码 809-817出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.copbio.2011.02.008
关键词
-
资金
- U.S. Department of Energy, BES [DE-FG02-06ER15762]
- National Institutes of Health ARRA [2R01GM068664-05A1]
- National Institutes of Health [1R01-DA028299, 1F32GM095061-01]
Protein engineering of cytochrome P450 monooxygenases (P450s) has been very successful in generating valuable non-natural activities and properties, allowing these powerful catalysts to be used for the synthesis of drug metabolites and in biosynthetic pathways for the production of precursors of artemisinin and paclitaxel. Collected experience indicates that the P450s are highly 'evolvable' - they are particularly robust to mutation in their active sites and readily accept new substrates and exhibit new selectivities. Their ability to adapt to new challenges upon mutation may reflect the nonpolar nature of their active sites as well as their high degree of conformational variability.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据